GE HealthCare price target lowered to $86 from $105 at Citi

Citi analyst Joanne Wuensch lowered the firm’s price target on GE HealthCare (GEHC) to $86 from $105 and keeps a Buy rating on the shares following Q1 results. The firm noted that GE HealthCare is one of the companies “most negatively impacted” by tariffs. However, Citi believes the underlying business “appears strong” and that key products are intact. GE Healthcare has a “long funnel” of mitigation opportunities that will depend on finalized tariff rates, according to the firm.